Loading provider…
Loading provider…
Rheumatology Physician in Baltimore, MD
NPI: 1548206683Primary Practice Location
JOHNS HOPKINS HOSPITAL, THE
1800 Orleans St, Baltimore, MD
Primary Employer
Jhu - Oncology
hopkinsmedicine.org
HQ Phone
Get M.D. Michelle's Phone Numberphone_androidMobile
Get M.D. Michelle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 230 | 480 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 26 | 26 |
Authors: Toro-Domínguez, Daniel, Martorell-Marugán, Jordi, Martinez-Bueno, Manuel, López-Domínguez, Raúl, Carnero-Montoro, Elena, Barturen, Guillermo, Goldman, Daniel, Petri, Michelle, Carmona-Sáez, Pedro, Alarcón-Riquelme, Marta E
Journal: Brief Bioinform
Authors: Surya Seshan, Doruk Erkan, Karen Costenbader, David Branch, Medha Barbhaiya, Thomas Ortel, David Garcia
Journal: Arthritis Care Res (Hoboken)
Publication Date: 2024-09-30
Authors: Diane Kamen, Meggan Mackay, Daniel Wallace, Rosalind Ramsey-Goldman, Mary Dooley, Kenneth Kalunian, Cynthia Aranow, Anca Askanase, Ellen Ginzler
Journal: Arthritis Care Res (Hoboken)
Publication Date: 2023-02-23
Lead Sponsor: Emergent BioSolutions
Collaborators: Biomedical Advanced Research and Development Authority
Intervention / Treatment: BIOLOGICAL: BioThrax, BIOLOGICAL: AV7909
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Upadacitinib, DRUG: Placebo for upadacitinib, DRUG: Elsubrutinib, DRUG: Placebo for elsubrutinib